Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Growth
16.03%
Quarterly · Period ending:
BIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported16.03%period ending
Latest reported16.03%period ending
BIO Quarterly EBITDA YoY % (22.44% → 16.03%)
Year-over-year change
High-resolution chart · PNG
BIO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 25.1204% | |
| 28.1086% | |
| 11.1379% | |
| 102.6563% | |
| 61.8603% | |
| 81.2061% | |
| 60% | |
| 70.6667% | |
| 52.0504% | |
| 20.5385% | |
| 26.087% | |
| -6.25% | |
| 0% | |
| 22.1477% | |
| -21.7687% | |
| -39.3939% | |
| -14.3885% | |
| -17.6796% | |
| 4.2553% | |
| 9.0909% | |
| 5.303% | |
| 7.1006% | |
| 4.4444% | |
| 6.1404% | |
| 1.5385% | |
| 8.3333% | |
| 164.7059% | |
| 83.871% | |
| 83.0986% | |
| 83.5294% | |
| -39.2857% | |
| -11.4286% | |
| -35.1145% | |
| 12% | |
| -14.6341% | |
| -100% | |
| 20.1835% | |
| -31.1927% | |
| 20.5882% | |
| 0% | |
| 15.9574% | |
| 62.6866% | |
| 17.2414% | |
| -2.5641% | |
| -83.3037% | |
| 105.3259% | |
| -87.4459% | |
| -84.0816% | |
| 11.4851% | |
| -27.0707% | |
| 18.4615% | |
| 25.964% | |
| 34.6667% | |
| -22.6766% | |
| 25.4019% | |
| 23.8854% | |
| 25% | |
| -21.5361% | |
| 22.4409% |